Healthcare
Live Price
Offline$6.25
+1.63% today
1Y Change
-45.59%
Window
Jun 20, 2025 → Jun 16, 2026
Coverage: 248 bars · Jun 20, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Upstream Bio, Inc. (UPB) is a Healthcare stock with a market cap of $510.00M and listed on NASDAQ. The stock last traded around $6.25 and down 45.6% across the available one-year price window (Jun 20, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +20.4%, EPS growth of -78.5%, a dividend yield of 0.0%. What stands out right now is revenue +20.4%, EPS -78.5%, free cash flow -123.3% with operating margin -5618.8% and ROIC -47.0%. Valuation already assumes a fairly strong business story at price/sales 179.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines UPB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
UPB
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
UPB Max Drawdown
-81.84%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for UPB and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.